Pamela Z New

University Of Texas Hlth Sci Ctr San Ant

$729,192

Attributed

$729,192

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.2K · FY2005–06

$10K$7.5K$5K$2.5K$0

'05

'06

Funding mix

By agency

NIH$729,192 · 5

By mechanism

M01$729,192 · 5

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Sci Ctr San Ant

Same institution · by research overlap

Eric K Rowinsky$9,623,858
S Gail Eckhardt$7,082,740
Michael G Brattain$16,576,364
Gregory R Mundy$7,763,862
Daniel D Von Hoff$23,238,156

Others in their field

Top investigators on “Human Therapy Evaluation”

Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
Barbara Driver · Westat, Inc.$206,347,735
Carol Nesel · Westat$188,148,170
Constance Ann Benson · University Of California, San Diego$179,950,251

Research focus

Human Therapy EvaluationClinical ResearchNeoplasm /Cancer ChemotherapyClinical Trial Phase IGliomaHuman SubjectAntineoplasticsDosageDrug Screening /EvaluationPhenylacetatesEnzyme InhibitorsIrinotecanNeoplasm /Cancer PharmacologyNeoplasm /Cancer Relapse /RecurrenceNeoplastic GrowthNeoplastic ProcessOutcomes ResearchAdult Human (21+)